Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
SUSPENDED
80 participants
OBSERVATIONAL
2014-11-30
2029-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mechanisms of Pregnancy Vascular Adaptations
NCT03806283
The Impact of Pregnancy and Pregnancy-associated Hypertension on Human Uterine Myometrial Artery Reactivity
NCT03888170
Berlin-Brandenburg Pregnancy Cohort
NCT03313024
Acute Labetalol Use in Preeclampsia
NCT03872336
Acute Control of Chronic Hypertension
NCT03877692
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Women with preeclampsia
Women delivered by cesarian section and with preeclampsia
No interventions assigned to this group
Women with dysfunctional labor
Women delivered with cesarian section due to dtsfunctional labor
No interventions assigned to this group
Women with cesarian section due to maternal request
Women with cesarian section due to maternal request
No interventions assigned to this group
Women with preamture labor
Women with pemature labor undergoing cesarian section
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
50 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Karolinska Institutet
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Helena Kopp Kallner
MD, PhD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dept of Obstetrics and Gynecology, Danderyd Hospital
Stockholm, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VAI
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.